Fructose sweetens antitumor responses

Stephanie Houston

DOI: https://doi.org/10.1038/s41590-023-01730-8

IF: 30.5

2024-01-03

Nature Immunology

Abstract:Fructose consumption is associated with tumor growth and metastasis, but its role in the antitumor immune response is unclear. In Cell Metabolism , Zhang et al. find that dietary fructose shapes adipocyte metabolism, which enhances CD8 + T cell responses and controls tumor growth. When mice were maintained on a high-fructose diet and challenged with B16-F10 melanoma cells, tumor growth was suppressed compared to mice on a conventional diet. Tumor-bearing mice on a high-fructose diet had fewer exhausted CD8 + T cells in the tumor and increased numbers of Ki-67 + IFNγ + CD8 + T cells, even when CD8 + T cells lacked expression of the fructose transporter GLUT5. Fructose treatment activated mTORC1 signaling in adipocytes and increased their production of leptin. In mice in which adipocytes lacked the mTORC1 complex component Raptor, leptin production was reduced and tumor growth increased. In a cohort of patients with lung cancer, the concentration of circulating fructose positively correlated with leptin levels and tumor-infiltrating CD8 + T cells, but this was not replicated in patients with colorectal cancer. Therefore, in some cancers, dietary fructose can control adipocyte metabolism to prime CD8 + T cell responses and thus control tumor growth.

immunology